Merck EBITDA 2010-2024 | MKKGY
Merck annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Merck EBITDA for the quarter ending June 30, 2024 was $1.582B, a 0.55% decline year-over-year.
- Merck EBITDA for the twelve months ending June 30, 2024 was $5.836B, a 9.58% decline year-over-year.
- Merck 2023 annual EBITDA was $5.942B, a 13.29% decline from 2022.
- Merck 2022 annual EBITDA was $6.853B, a 2.49% decline from 2021.
- Merck 2021 annual EBITDA was $7.028B, a 24.97% increase from 2020.
Merck Annual EBITDA
(Millions of US $) |
| 2023 |
$5,942 |
| 2022 |
$6,853 |
| 2021 |
$7,028 |
| 2020 |
$5,624 |
| 2019 |
$4,552 |
| 2018 |
$4,178 |
| 2017 |
$4,841 |
| 2016 |
$4,887 |
| 2015 |
$3,722 |
| 2014 |
$4,151 |
| 2013 |
$4,830 |
| 2012 |
$3,780 |
| 2011 |
$1,555 |
| 2010 |
$12,338 |
| 2009 |
$10,807 |
Merck Quarterly EBITDA
(Millions of US $) |
| 2024-06-30 |
$1,582 |
| 2024-03-31 |
$1,504 |
| 2023-12-31 |
$1,208 |
| 2023-09-30 |
$1,543 |
| 2023-06-30 |
$1,591 |
| 2023-03-31 |
$1,600 |
| 2022-12-31 |
$1,601 |
| 2022-09-30 |
$1,662 |
| 2022-06-30 |
$1,791 |
| 2022-03-31 |
$1,799 |
| 2021-12-31 |
$1,753 |
| 2021-09-30 |
$1,738 |
| 2021-06-30 |
$1,768 |
| 2021-03-31 |
$1,769 |
| 2020-12-31 |
$1,244 |
| 2020-09-30 |
$1,958 |
| 2020-06-30 |
$1,156 |
| 2020-03-31 |
$1,265 |
| 2019-12-31 |
$1,202 |
| 2019-09-30 |
$1,183 |
| 2019-06-30 |
$1,199 |
| 2019-03-31 |
$968 |
| 2018-12-31 |
$985 |
| 2018-09-30 |
$1,042 |
| 2018-06-30 |
$987 |
| 2018-03-31 |
$1,164 |
| 2017-12-31 |
$822 |
| 2017-09-30 |
$1,613 |
| 2017-06-30 |
$1,124 |
| 2017-03-31 |
$1,282 |
| 2016-12-31 |
$1,027 |
| 2016-09-30 |
$1,226 |
| 2016-06-30 |
$1,220 |
| 2016-03-31 |
$1,414 |
| 2015-12-31 |
$886 |
| 2015-09-30 |
$1,023 |
| 2015-06-30 |
$926 |
| 2015-03-31 |
$941 |
| 2014-12-31 |
$620 |
| 2014-09-30 |
$1,009 |
| 2014-06-30 |
$952 |
| 2014-03-31 |
$1,057 |
| 2013-12-31 |
$1,155 |
| 2013-09-30 |
$1,259 |
| 2013-06-30 |
$1,292 |
| 2013-03-31 |
$1,111 |
| 2012-12-31 |
$3,646 |
| 2012-09-30 |
$601 |
| 2012-06-30 |
$79 |
| 2012-03-31 |
$3,274 |
| 2011-12-31 |
$3,311 |
| 2011-09-30 |
$3,585 |
| 2011-06-30 |
$151 |
| 2011-03-31 |
$3,505 |
| 2010-12-31 |
$3,707 |
| 2010-09-30 |
$618 |
| 2010-06-30 |
$2,695 |
| 2010-03-31 |
$2,791 |
| 2009-12-31 |
$2,983 |
| 2009-09-30 |
$2,778 |
| 2009-06-30 |
$2,590 |
| 2009-03-31 |
$2,456 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
